AI-driven platform that predicts patient-specific intracellular targets and designs personalized or semi-personalized therapeutics to reach disease-driving proteins inaccessible to conventional biologics. Targets patients with diseases lacking treatment options and drug developers seeking scalable, affordable intracellular-targeting therapies.